S&P 500 Futures
(0.29%) 5 169.50 points
Dow Jones Futures
(0.23%) 38 922 points
Nasdaq Futures
(0.27%) 18 050 points
Oil
(1.04%) $78.92
Gas
(0.61%) $2.16
Gold
(0.86%) $2 328.40
Silver
(2.73%) $27.42
Platinum
(1.11%) $976.05
USD/EUR
(-0.01%) $0.929
USD/NOK
(-0.25%) $10.85
USD/GBP
(-0.24%) $0.795
USD/RUB
(0.01%) $91.46

实时更新: Fennec Pharmaceuticals [FENC]

交易所: NASDAQ 部门: Healthcare 工业: Biotechnology
Upcoming Earnings Alert

3 days till quarter result
(bmo 2024-05-09)

Expected move: +/- 7.41%

最后更新时间4 May 2024 @ 04:00

1.54% $ 9.23

出售 117834 min ago

@ $9.99

发出时间: 14 Feb 2024 @ 22:33


回报率: -7.61%


上一信号: Feb 13 - 22:38


上一信号: 购买


回报率: -0.10 %

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 04:00):

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients...

Stats
今日成交量 71 279.00
平均成交量 138 068
市值 250.13M
EPS $0 ( 2024-03-21 )
下一个收益日期 ( $-0.0400 ) 2024-05-09
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -15.38
ATR14 $0.0260 (0.28%)
Insider Trading
Date Person Action Amount type
2024-04-30 Andrade Robert Buy 1 042 Common shares
2024-04-30 Raykov Rosty Buy 2 431 Common shares
2024-05-01 Raykov Rosty Sell 2 431 Common shares
2024-04-18 Haigh Adrian Buy 22 222 Common Shares
2024-04-17 Haigh Adrian Buy 22 222 Common Shares
INSIDER POWER
8.47
Last 100 transactions
Buy: 1 356 995 | Sell: 926 579

音量 相关性

長: 0.03 (neutral)
短: -0.96 (very strong negative)
Signal:(34.82) Neutral

Fennec Pharmaceuticals 相关性

10 最正相关
JD0.927
NAKD0.916
GBNH0.912
WLTW0.907
SIRI0.906
LSXMA0.906
LSXMK0.906
DTSS0.905
ALXO0.904
GOOD0.903
10 最负相关
PAE-0.924
GPACU-0.915
CMLF-0.909
LMNR-0.909
PUCKU-0.905
RAM-0.905
GXII-0.904
SGEN-0.902
CSLMU-0.9
EBSB-0.896

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Fennec Pharmaceuticals 相关性 - 货币/商品

The country flag 0.21
( neutral )
The country flag 0.58
( weak )
The country flag 0.00
( neutral )
The country flag -0.40
( neutral )
The country flag 0.12
( neutral )
The country flag 0.80
( moderate )

Fennec Pharmaceuticals 财务报表

Annual 2023
营收: $21.64M
毛利润: $20.36M (94.08 %)
EPS: $-0.610
FY 2023
营收: $21.64M
毛利润: $20.36M (94.08 %)
EPS: $-0.610
FY 2022
营收: $1.54M
毛利润: $1.45M (94.40 %)
EPS: $-0.950
FY 2021
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-0.667

Financial Reports:

No articles found.

Fennec Pharmaceuticals

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。